-
Puli Pharmaceutical Etibatide Injection Obtained Drug Registration Approval
Time of Update: 2021-07-27
On July 25, Puli Pharmaceuticals announced that it had recently received a drug registration approval for eptifibatide injection issued by the State Food and Drug Administration.
It was approved for listing in Europe in July 1999 and is now under the responsibility of GlaxoSmithKline.
-
Zhifei Biological and Human Welfare Pharmaceutical Innovative Drugs Enter the Administrative Approval Stage
Time of Update: 2021-07-06
Being able to enter the administrative approval stage means that the conclusion of the technical review is "approved.
-
What is the cause of "hematuria
Time of Update: 2021-06-04
Through the examination of the morphology of urine red blood cells, it can be preliminarily judged whether it is "glomerular hematuria (also called medical hematuria)" or "non-glomerular hematuria (also called surgical hematuria)", if it is the former , You need to go to the nephrology internal medicine department to further improve the relevant examinations to determine which type of kidney disease it is.
-
up to date
Time of Update: 2021-06-01
On May 26, the State Food and Drug Administration issued an announcement on protected varieties of traditional Chinese medicines.
will continue to be given 2 Level of protection, the protection period and the number of protected varieties are respectively May 06, 2021-May 9, 2027, ZYB20720200101.
-
Johnson & Johnson's new indication for daratumumab is about to be approved in China
Time of Update: 2021-05-23
Although many progresses have been made in the treatment of multiple myeloma in recent years, most patients still face the problem of relapse or drug resistance.
-
FDA revokes emergency use authorization for Eli Lilly's new crown antibody drug
Time of Update: 2021-05-02
It is worth noting that before the FDA announced on Friday that the emergency use authorization of Eli Lilly's new crown antibody drug was revoked, Eli Lilly had already admitted that due to some mutant viruses circulating in the United States, the effect of treatment with bamlanivimab alone has declined, and Eli Lilly will Focus on promoting the cocktail therapy of bamlanivimab and the company's second antibody drug etesevimab.
-
Preliminary Pharmaceuticals obtains marketing approval for ganciclovir for injection from the Italian Food and Drug Administration
Time of Update: 2021-04-14
On April 1, Hainan Puli Pharmaceuticals issued an announcement that the company recently received a marketing authorization for ganciclovir for injection issued by the Italian Drug Administration (AIFA).
500mg ganciclovir for injection was applied by Roche Palo in June 1989 to be marketed in the United States under the trade name CYTOVENE®-IV.
-
Diabetes Care: New hypoglycemic drugs can effectively improve Asian cardiovascular risk
Time of Update: 2021-04-13
Compared with whites, Asians may gain greater cardiovascular death/ heart failure benefits from SGLT2is, and in patients with type 2 diabetes, MACE benefits from GLP-1RAs.
Compared with whites, Asians may gain greater cardiovascular death/ heart failure benefits from SGLT2is, and in patients with type 2 diabetes, MACE benefits from GLP-1RAs.
-
Suqian Market Supervision Administration Phase 3 Food Safety Supervision Sampling Information Announcement in 2021
Time of Update: 2021-03-20
html" class="zdbq" title="Sampling inspection related food information" target="_blank">sampling inspection items are notified as follows: 2021 January-February Suqian City Market foodmate.
html" class="zdbq" title="Food information related to national food safety standards" target="_blank">national food safety standard inspection and judgment, 240 batches of qualified samples and 3 batches of unqualified samples are foodmate.
-
The results of the fourth batch of national elections were officially announced
Time of Update: 2021-03-08
starting from the third batch of national mining, the original drug research enterprises running mentality is becoming increasingly obvious, many foreign enterprises quoted higher than the highest effective declared price, equivalent to directly give up the collection market.
-
Nine kinds of Chinese medicine were incorporated into the pilot management of food medicine
Time of Update: 2021-02-21
, the State Health and Health Commission issued a "notice on the party participation and other 9 kinds of substances in accordance with tradition is both food and Traditional Chinese medicine materia
-
New chinese epilepsy drug! Ukip Vimpat is approved for use in adolescent and adult epilepsy patients
Time of Update: 2021-02-17
In the European Union, Vimpat was first approved in September 2008 as an ancillary drug for the treatment of partial seizure epilepsy (accompanied or not accompanied by secondary comprehensive seizure epilepsy) in children, adolescents and adults aged 4 years and older.
-
138 companies in the first three quarters of net profit increase of 18% pharmaceutical industry sector recovery is evident
Time of Update: 2021-02-07
According to the data over the past two years, the average growth rate of net profit in the pharmaceutical industry sector is slower than the industry average, and the third quarter report is showing signs of recovery.
-
Clinical applications for bio-eye gene therapy in Newforth were accepted
Time of Update: 2021-01-25
Source: Pharmaceutical Mission, January 19, China's State Drug Administration Drug Review Center (CDE) announced that Newforth Bio-Ophthalmology Gene Therapy NR082 Eye Injection (NFS-01 Project) was declared clinical trials and accepted.
screenshot source: NR082 is the first drug candidate developed by Newforth Bio, after completing clinical trials of the global large sample LHON gene therapy.
-
Shanghai sampling 6 categories of 649 batches of food, this batch of convenient food detection of the total number of falles exceeded the standard
Time of Update: 2021-01-21
samples for convenience food 1 batch, non-conforming items involving the total number of falles exceeded the standard.
